(CARA) FDA priority for pruritus drug hemodialysis.

Health Master

Junior member
50 Day MA positive, Enterprise Value/Market Cap attractive, EPS surprise of 400%, Corporate Governance 90% (ISS), MACD positive, Stochastics oversold, Bullish rounding bottom 1yr formation, 13F Put/Call Ratio improvement.

13F filings- CARA.png
AdBlock Detected

We get it, advertisements are annoying!

But it's thanks to our sponsors that access to Trade2Win remains free for all. By viewing our ads you help us pay our bills, so please support the site and disable your AdBlocker.

I've Disabled AdBlock    No Thanks